Advanced Filters
noise
Found 64,783 clinical trials
M Massimo Falconi, Professor

Registry of Subjects at Risk of Pancreatic Cancer

IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.

18 - 80 years of age All Phase N/A

Clinical Prognostic Score to Predict Relapse in VL

This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia. Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify …

12 years of age All Phase N/A
D David CL Lam, MBBS, FRCP(Edin), FCCP, FACP

Screening for Lung Cancer in Subjects With Family History of Lung Cancer

Lung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDCT screening for lung cancer. In Hong Kong, …

50 - 75 years of age All Phase N/A
S Sheng Zhang, MD

Dementia Risk Registry for Young and Middle-aged CSVD Patients in the Next 10 Years

Age-related cerebral small-vessel disease (CSVD) is a major cause of dementia, predominantly affecting individuals over 60 years of age, with a prevalence exceeding 70% in the elderly population. However, the correlation between the burden of CSVD and the progression of cognitive impairment in young and middle-aged individuals remains uncertain. DREAM-10 …

30 - 60 years of age All Phase N/A

Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the …

18 years of age All Phase N/A
S Site Public Contact

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors …

years of age All Phase N/A
F Fanny WS KO, MD

A Prospective Study Readmission and Mortality of COPD Patients

Chronic obstructive pulmonary disease (COPD) is a common disease worldwide with a high burden on healthcare resources. The prevalence of COPD varied from 11.4 to 26.1% according to a recent multi-city population study using spirometry. In Hong Kong (HK), the prevalence rates of COPD in the elderly population aged ≥60 …

40 years of age All Phase N/A

Future Optimal Research and Care Evaluation

Rationale: Acute coronary syndrome (ACS) is the leading cause of death worldwide. To improve cardiovascular care, research is needed. Current guidelines are mainly based on well controlled RCT's, though evaluation of the impact of such RCT's in the real world is missing. In order to evaluate the impact and to …

18 years of age All Phase N/A
T Takehiro Okabayashi

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

postoperative outcomes were evaluated by using inBody test

18 - 90 years of age All Phase N/A
Z Zengliang Jiang, PhD

Westlake Longevity Cohort

The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians, senior citizens and their family members up to three generations living in Lishui, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. Another aim of …

50 years of age All Phase N/A

Simplify language using AI